ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
38 announcements with these filters
Apollo Hospitals Enterprise Limited has scheduled a Board meeting on May 20, 2026, to approve audited financial results for the year ended March 31, 2026. The Board will also consider recommending a final dividend for the financial year. The trading window for designated persons is closed until May 22, 2026.
Apollo Hospitals Enterprise Ltd has scheduled a Board meeting for May 20, 2026. The Board will consider annual audited standalone and consolidated financial results for FY 2025-26 and recommend a final dividend. The trading window for designated persons remains closed until May 22, 2026.
Apollo Hospitals received an NCLT order regarding its proposed composite scheme of arrangement. The tribunal modified meeting dates for equity shareholders and unsecured creditors of various group companies to May 26-27, 2026. This follows the tribunal's refusal to dispense with the meeting of secured creditors.
Apollo Hospitals Enterprise Limited received an NCLT order regarding its composite scheme of arrangement. The tribunal directed convening meetings for secured/unsecured creditors and shareholders in May 2026, while dismissing a prayer to dispense with the secured creditors' meeting.
Apollo Hospitals Enterprise Limited acquired an additional 775,744 equity shares in Apollo Health and Lifestyle Limited (AHLL) for ₹18.69 Crore. This transaction increases the company's total shareholding in AHLL from 99.42% to 100%, making it a wholly-owned subsidiary.
Apollo Hospitals Enterprise Limited received the NCLT's certified order regarding its composite scheme of arrangement involving Apollo Healthco, Keimed, and Apollo Healthtech. The Tribunal has directed the convening of shareholder and creditor meetings in May 2026. This legal milestone advances the company's strategic restructuring and business consolidation plans.
Apollo Hospitals Enterprise Ltd submitted its quarterly certificate under Regulation 74(5) for the period ended March 31, 2026. The filing confirms that security certificates received for dematerialization were processed, mutilated, and cancelled as per SEBI regulations. This is a routine administrative compliance update for investors.
Apollo Hospitals Enterprise Limited received NCLT Chennai approval to convene meetings for a composite scheme of arrangement. The scheme involves demerging its identified business undertaking into Apollo Healthtech Limited and consolidating pharmacy distribution units. This restructuring aims to unlock value and streamline specialized business segments for shareholders and creditors.